Heidi Raises $65M to Build AI Care Partners for Clinicians
▼ Summary
– Healthcare AI company Heidi raised $65 million in Series B funding, valuing the company at $465 million and bringing total funding to nearly $100 million.
– The funding will accelerate Heidi’s mission to build an AI Care Partner that automates clinical documentation, evidence search, and follow-up communications to expand clinician capacity.
– Heidi has already returned over 18 million hours to clinicians by streamlining administrative tasks and supports over two million weekly patient consults across 116 countries.
– The company is expanding its presence in the USA, UK, and Canadian markets and has partnerships with major healthcare providers like Cambridge University Hospitals and Beth Israel Lahey Health.
– Heidi announced new executive appointments, including Paul Williamson as Chief Revenue Officer and Dr. Simon Kos as Chief Medical Officer, to support its growth and vision.
Healthcare AI innovator Heidi has successfully secured $65 million in a Series B investment round, significantly boosting its mission to develop artificial intelligence care partners for medical professionals. This substantial capital infusion, spearheaded by Point72 Private Investments with ongoing support from Blackbird, Headline, and Latitude, brings the company’s valuation to $465 million and cumulative funding close to $100 million.
The fresh capital will drive Heidi’s development of an AI Care Partner designed to work alongside healthcare providers. This technology aims to dramatically expand clinical capacity by automating essential but time-consuming tasks like clinical documentation, evidence searches, and patient follow-up communications. Research consistently shows that medical professionals devote nearly equal time to administrative duties and direct patient care. Within just eighteen months, Heidi’s platform has already given back more than 18 million hours to frontline clinicians by streamlining these critical administrative functions.
Dr. Thomas Kelly, Heidi’s CEO and co-founder who previously worked as a vascular surgical resident, emphasized the critical nature of their mission. “The current situation is simply unsustainable,” he stated. “Healthcare demands keep climbing while clinical availability keeps shrinking. Creating a viable healthcare future means expanding clinical capacity without sacrificing clinician wellbeing or patient safety. That fundamental challenge is why I established Heidi—to develop an AI Care Partner that supports clinicians, enabling them to provide the quality care they’ve dedicated their careers to delivering.”
Heidi’s platform has gained remarkable traction across the global healthcare community. Tens of thousands of clinicians representing more than 200 medical specialties now rely on Heidi to manage administrative overload. Over the past year and a half, the technology has supported 73 million patient consultations and currently handles over two million weekly consults across 116 countries in 110 different languages.
This Series B funding will fuel Heidi’s expansion plans, including growing their team, establishing additional office locations, and strengthening local support networks throughout the United States, United Kingdom, and Canadian markets. The company will also build upon its clinician-led adoption in France, Spain, Germany, Ireland, South Africa, Singapore, and Hong Kong.
Major healthcare organizations worldwide are implementing Heidi’s AI capabilities. In the United Kingdom, Modality Partnership selected Heidi for the largest ambient AI deployment in the country, while Cambridge University Hospitals NHS Foundation Trust is implementing the technology. Pilot programs are underway with NHS Trusts across the North West London Acute Provider Collaborative, serving approximately 2.2 million residents, and with One LSC, the collective of five NHS Trusts in Lancashire and South Cumbria covering nearly 1.8 million people.
Across the Atlantic, Beth Israel Lahey Health, Massachusetts’ largest hospital network, has partnered with Heidi. MaineGeneral, operating Maine’s biggest outpatient center and one of the state’s largest hospital networks, identifies Heidi as a “transformation partner.” Canada’s Yukon Government has officially selected Heidi as its preferred provider, while Australia’s public health system sees implementation with Monash Health across forty facilities serving 1.6 million people, plus Queensland Health Children’s Hospital and Health Service, which provides specialized care for children and young people. New Zealand’s Health Ministry has formally endorsed Heidi as one of only two healthcare AI providers deemed safe for trials within the public health system.
Sri Chandrasekar, Managing Partner at lead investor Point72 Private Investments, explained their decision to back Heidi. “We’re convinced that administrative burdens significantly contribute to clinician burnout and capacity limitations throughout healthcare systems,” Chandrasekar noted. “Heidi’s platform offers genuine potential to meaningfully enhance how clinicians handle administrative workflows. Their demonstrated adoption rates within health systems impressed us, and we’re enthusiastic about supporting their vision to expand healthcare capacity while maintaining the essential human connection in patient care.”
Heidi simultaneously announced two key executive appointments. Paul Williamson joins as Chief Revenue Officer, bringing experience from his previous role as Head of Revenue at Plaid. “Throughout my career,” Williamson commented, “I’ve intentionally worked with companies that transformed their industries—from Salesforce in customer relationship management to Plaid in financial services. Today, I’m joining Heidi’s mission to redefine healthcare in this new era of artificial intelligence.”
Dr. Simon Kos, formerly Chief Medical Officer at Microsoft, assumes the same role at Heidi. “With Heidi supporting them,” Dr. Kos observed, “clinicians not only enhance their own care delivery experience but also improve the patient’s experience of receiving care. Heidi’s ambitious vision reaches beyond current ambient voice technology toward a future where every clinician can harness AI to expand their clinical capacity while safeguarding the human touch in healthcare.”
(Source: ITWire Australia)
